NIS Measles Virus (intra-tumoral)

NIS measles virus · Vyriad, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NIS Measles Virus (intra-tumoral), covering 2023-07-21 to 2023-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab [Phase 1]